A Companion Diagnostic (CDx) in Japan is a test used to identify suitable patients for specific drug treatments, particularly in personalized medicine. It’s essential for determining the efficacy and safety of a targeted therapy, often used in oncology, by predicting patient response based on their genetic profile.
